Fiat Chrysler Failed To Report Deaths, Injuries Linked To Safety Issues: NHTSA

Government highway safety officials have announced that they are reviewing new problems with Fiat Chrysler’s vehicle defect reporting systems, after the agency discovered that the automaker has significantly underreported injuries, deaths, and other problems associated with their vehicles. 

Under the Motor Vehicle Safety Act, known as the TREAD Act, automobile manufacturers are required to document Early Warning Reporting (EWR) and notify the National Highway Traffic Safety Administration (NHTSA) every three months about incidents that have resulted in injury, death, property damage, warranty claims or any mechanical defects discovered, regardless of whether any injury has occurred.

The Early Warning Reporting data is collected by NHTSA to help identify trends and potential issues that may impact a large number of automobiles, allowing the agency to initiate recalls and remove dangerous designs and defects from vehicles to prevent further injury or death.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

According to a statement by the NHTSA, Fiat Chrysler America’s Early Warning Reporting system has substantial problems, which may have resulted in a a substantial under-reporting of incidents in violation of the TREAD Act.

Due to the significant failure to meet the manufacturer’s safety obligations, NHTSA Administrator, Mark Rosekind, announced that the agency will be taking further action after gathering more information about the scope and cause of the reporting system failures.

In a statement issued last week, Chrysler responded to the NHTSA’s allegations and suggested that there may have been gaps in reporting while the company was the subject of a prior investigation stemming from problems with 23 separate Chrysler recalls.

Chrysler and NHTSA entered a consent order over the prior issues in July, which resulted in a $70 million cash penalty and another $20 million the auto maker was required to spend on meeting performance requirements. The agreement also called for Chrysler to pay another $15 million if an independent monitor discovered more safety violations.

The current investigation by the NHTSA could lead to further penalties and fines if Chrysler is found to have allowed gaps in their reporting systems. The NHTSA’s report did not indicate how many incidents had gone under-reported but pending the investigation, more vehicles could be recalled due to unknown defects.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted today)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.